BIOMAT Database Logo BIOMAT Database Logo

Study of several genetic markers of two recombinants derived from autochthonous influenza virus type A strains. 1982

A Mihail, and R Repanovici

Two recombinants derived from autochthonous influenza virus type A strains were studied as regards neuraminidase activity, the rate of elution from chicken RBC and the sensitivity to nonspecific horse serum inhibitors. Neuraminidase activity was lower in the A(H1N1) recombinant and in its collection and wild-type parents belonging to the same subtype than in the A(H3N2) recombinant and parental strains; the elution rate was much higher in the former than in the latter. In contrast to the parental strains, both recombinants were resistant to horse serum inhibitors.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D001790 Blood Physiological Phenomena Physiological processes and properties of the BLOOD. Blood Physiologic Processes,Blood Physiological Processes,Blood Physiology,Blood Physiological Concepts,Blood Physiological Phenomenon,Physiology, Blood,Blood Physiological Concept,Blood Physiological Phenomenas,Concept, Blood Physiological,Concepts, Blood Physiological,Phenomena, Blood Physiological,Phenomenon, Blood Physiological,Physiologic Processes, Blood,Physiological Concept, Blood,Physiological Concepts, Blood,Physiological Phenomenon, Blood,Processes, Blood Physiologic,Processes, Blood Physiological
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006387 Hemagglutination, Viral Agglutination of ERYTHROCYTES by a virus. Hemagglutinations, Viral,Viral Hemagglutination,Viral Hemagglutinations
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

A Mihail, and R Repanovici
Study of recombinants derived from autochthonous influenza virus type A strains.
January 1981, Virologie,
A Mihail, and R Repanovici
Study of the genetic characters of vaccine strains of type A-2 influenza virus.
January 1961, Problems of virology,
A Mihail, and R Repanovici
Genetic studies of influenza viruses. 3. Production of plaque-type recombinants with A0 and A1 strains.
May 1966, Virology,
A Mihail, and R Repanovici
RNAs of influenza virus recombinants derived from parents of known virulence for man.
January 1977, Archives of virology,
A Mihail, and R Repanovici
[Inhibition of several strains of influenza virus type A and B by phenolic polymers].
January 1986, Biomedica biochimica acta,
A Mihail, and R Repanovici
Studies on genetic recombinants of influenza virus: fundamental studies on recombinant influenza-virus vaccines.
December 1975, The Kitasato archives of experimental medicine,
A Mihail, and R Repanovici
Natural recombinants derived from different patterns of recombination between two PCV2b parental strains.
June 2011, Virus research,
A Mihail, and R Repanovici
[Isolation of spontaneous mutants from influenza A virus recombinants after several plaque passages in embryonic chicken cells].
January 1983, Virologie,
A Mihail, and R Repanovici
[Production of recombinants antigenically identical to influenza virus strains circulating in nature].
January 1979, Voprosy virusologii,
A Mihail, and R Repanovici
Genetic recombination between temperature-sensitive and wild-type influenza A virus strains.
January 1983, Acta virologica,
Copied contents to your clipboard!